Clinical Trial in Males With BPH (Enlarged Prostate)

Sponsor
Sanofi (Industry)
Overall Status
Completed
CT.gov ID
NCT00029822
Collaborator
(none)
1,522
54
46
28.2
0.6

Study Details

Study Description

Brief Summary

A study to determine the effect on prevention of Acute Urinary Retention (inability to urinate) in males with an enlarged prostate, also known as BPH.

  • Free study-related medical care provided.
Condition or Disease Intervention/Treatment Phase
  • Drug: Alfuzosin (SL770499)
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
1522 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Prevention
Official Title:
Long-Term, Efficacy and Safety of Alfuzosin 10 MG OD on the Risk of Acute Urinary Retention and the Need for Surgery in Patients With BPH. A Two Year, Randomized, Multicenter, Double-Blind, Parallel Group, Placebo-Controlled Study.
Study Start Date :
May 1, 2001
Actual Study Completion Date :
Mar 1, 2005

Outcome Measures

Primary Outcome Measures

  1. occurrence of first episode of acute urinary retention (AUR) []

Secondary Outcome Measures

  1. need for benign prostatic hyperplasia (BPH)-related surgery, international prostate symptoms score (IPSS) []

Eligibility Criteria

Criteria

Ages Eligible for Study:
55 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
  • Has been suffering for at least 6 months with any of the following symptoms:

  • daytime or nighttime urinary frequency

  • urgent feeling to urinate

  • difficulty starting urinary stream

  • interruption of urinary stream

  • feeling of incomplete urination

  • Has not had a previous episode of acute urinary retention

  • Has not been diagnosed with prostate cancer

  • Has not had previous prostate surgery

  • Is not an insulin-dependent diabetic

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical Affiliated Research Center, Inc Huntsville Alabama United States 35801
2 San Diego Urology Center La Mesa California United States 91942
3 San Bernardino Urology Associates San Bernardino California United States 92404
4 San Diego Urological Medical Group San Diego California United States 92101
5 Pacific Clinical Research Santa Monica California United States 90404
6 Urology Research Options Aurora Colorado United States 80012
7 Connecticut Clinical Research Center Waterbury Connecticut United States 06708-2652
8 South Florida Medical Research Aventura Florida United States 33180
9 Tampa Bay Medical Research, Inc. Clearwater Florida United States 34621
10 Advanced Research Institute New Port Richey Florida United States 34652
11 Renstar Medical Research Ocala Florida United States 34474
12 Renstar Medical Research Plantation Florida United States 33324
13 Urology Associates Marietta Georgia United States 30060
14 Northwestern Center for Clinical Research Chicago Illinois United States 60611
15 Welborn Clinic Evansville Indiana United States 47714
16 Northeast Indiana Research Fort Wayne Indiana United States 46804-4128
17 Urology of Indiana, LLC Indianapolis Indiana United States 46202
18 Maryland Prostate Cancer Baltimore Maryland United States 21201
19 Maryland Urology Association Towson Maryland United States 21204
20 Newton Wellesley Urology Newton Massachusetts United States 02462
21 Lakeside Urology, P.C. St. Joseph Michigan United States 49085-2521
22 Se Urology Network Southaven Mississippi United States 38671
23 Weill Cornell Medical Center New York New York United States 10021
24 Advanced Clinical Trials Eugene Oregon United States 97401
25 Albert Einstein Medical Center Philadelphia Pennsylvania United States 19141
26 Center for Urologic Care West Reading Pennsylvania United States 19611
27 Matrix Research Greenville South Carolina United States 29650
28 Ut Medical Group, Inc. Memphis Tennessee United States 38103-3446
29 Murfreesboro Medical Center Murfreesboro Tennessee United States 37130
30 nTouch Research Corporation Dallas Texas United States 75230
31 Urology Consultants, P.A. San Antonio Texas United States 78229
32 Urology Associates Fredericksburg Virginia United States 22401
33 Jeffrey Frankel Seattle Washington United States 98166-3059
34 University of Wisconsin Hospital & Clinics Madison Wisconsin United States 53792
35 Midwest Research Specialists, LLC Milwaukee Wisconsin United States 53209
36 Sanofi-aventis Administrative Office Macquarie Park Australia
37 Sanofi-aventis Administrative Office Sofia Bulgaria
38 Sanofi-aventis Administrative Office Laval Canada
39 Sanofi-aventis Administrative Office Horsholm Denmark
40 Sanofi-aventis Administrative Office Helsinki Finland
41 Sanofi-aventis Administrative Office Athens Greece
42 Sanofi-aventis Administrative Office Budapest Hungary
43 Edith Wolfson Hospital Holon Israel 58100
44 Sapir Med. Center - Meir General Hospital Kfar Saba Israel 44281
45 Rabin Medical Center-Golda Campus Petah Tikvah Israel 44281
46 Sourasky Med. Center-Ichilov Hospital Tel Aviv Israel 44281
47 Sanofi-aventis Administrative Office Gouda Netherlands
48 Sanofi-aventis Administrative Office Lysaker Norway
49 Sanofi-aventis Administrative Office Warszawa Poland
50 Sanofi-aventis Administrative Office Porto Salvo Portugal
51 Sanofi-aventis Administrative Office Bucuresti Romania
52 Sanofi-aventis Administrative Office Midrand South Africa
53 Sanofi-aventis Administrative Office Barcelona Spain
54 Sanofi-aventis Administrative Office Bromma Sweden

Sponsors and Collaborators

  • Sanofi

Investigators

  • Study Director: ICD CSD, Sanofi

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00029822
Other Study ID Numbers:
  • EFC4485
  • SL770499
First Posted:
Jan 24, 2002
Last Update Posted:
Jun 9, 2008
Last Verified:
Jun 1, 2008

Study Results

No Results Posted as of Jun 9, 2008